News from us and our partners

Tags

Topics

0 results

News
14 March, 2024
Amolyt Pharma enters into definitive agreement to be acquired by AstraZeneca
News
14 March, 2024
Elicit Plant announces its upcoming US biosolution launch with demonstrated 20% reduction of water consumption in broad acre crops
News
14 March, 2024
Mission Therapeutics raises £25.2 million to progress clinical candidates in the area of mitophagy
News
12 March, 2024
Mainstay Medical publishes ReActiv8 age comparison data
News
11 March, 2024
Sensorion announces it has met primary endpoint for SENS-401 Phase 2a Clinical Study for residual hearing preservation
News
7 March, 2024
Inventiva resumes screening in Phase 3 trial of lanifibranor
News
7 March, 2024
NodThera’s NLRP3 inhibitor NT-0796 reverses neuroinflammation in Parkinson’s disease phase Ib/IIa trial
News
7 March, 2024
Signature of a partnership agreement with Kiro
News
7 March, 2024
AFYREN and SUEZ collaborate on organic waste recovery
News
7 March, 2024
Elicit Plant appoints Slavica Djonovic as CSO
News
6 March, 2024
Gradient Denervation Technologies enrolls first patient in early feasibility study of pulmonary artery denervation system
News
6 March, 2024
Asceneuron expands scientific Advisory Board with world leading experts in neurodegenerative diseases
News
3 March, 2024
Sitryx appoints COO and head of clinical operations
News
26 February, 2024
Mainstay Medical announces US$125 million equity financing transaction
News
21 February, 2024
HighLife appoints Prof. Stephen Brecker as CMO
News
20 February, 2024
Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology

Amolyt Pharma enters into definitive agreement to be acquired by AstraZeneca

Elicit Plant announces its upcoming US biosolution launch with demonstrated 20% reduction of water consumption in broad acre crops

Mission Therapeutics raises £25.2 million to progress clinical candidates in the area of mitophagy

Mainstay Medical publishes ReActiv8 age comparison data

Sensorion announces it has met primary endpoint for SENS-401 Phase 2a Clinical Study for residual hearing preservation

Inventiva resumes screening in Phase 3 trial of lanifibranor

NodThera’s NLRP3 inhibitor NT-0796 reverses neuroinflammation in Parkinson’s disease phase Ib/IIa trial

Signature of a partnership agreement with Kiro

AFYREN and SUEZ collaborate on organic waste recovery

Elicit Plant appoints Slavica Djonovic as CSO

Gradient Denervation Technologies enrolls first patient in early feasibility study of pulmonary artery denervation system

Asceneuron expands scientific Advisory Board with world leading experts in neurodegenerative diseases

Sitryx appoints COO and head of clinical operations

Mainstay Medical announces US$125 million equity financing transaction

HighLife appoints Prof. Stephen Brecker as CMO

Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology